or Try an Advanced Search...

    Technical Analysis for MOLN - Molecular Partners AG

    Grade Last Price % Change Price Change
    C 5.20 -4.76% -0.26
    MOLN closed down 4.76 percent on Wednesday, November 20, 2024, on 1.4 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Flat Down Down
    Historical MOLN trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    MACD Bearish Centerline Cross Bearish 0.00%
    20 DMA Resistance Bearish -4.76%
    Shooting Star Candlestick Bearish -4.76%
    50 DMA Support Bullish -4.76%
    Doji - Bearish? Reversal -4.76%
    Outside Day Range Expansion -4.76%
    Gapped Down Weakness -4.76%
    Crossed Above 50 DMA Bullish -10.81%
    Stochastic Buy Signal Bullish -10.81%
    Older End-of-Day Signals for MOLN ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support 1 day ago
    50 DMA Support 1 day ago
    Rose Above Previous Day's High 1 day ago
    Outside Day 1 day ago
    Fell Below Previous Day's Low 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    MOLN Chart by TradingView
    Basic chart:

    Profile

    Molecular Partners AG is a clinical-stage biotech company developing DARPin® therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Pharmaceutical Drugs Infectious Diseases Molecular Partners

    Is MOLN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 7 Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024
    Nov 5 Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition
    Oct 31 Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going
    Oct 25 Molecular Partners prices $20M offering
    Oct 25 Molecular Partners Announces Pricing of $20 Million Underwritten Offering
    Oct 23 Molecular Partners Expands Radio-DARPin Collaboration
    Oct 4 Molecular Partners Announces upcoming poster presentations at the 2024 SITC Annual Meeting
    Sep 27 Molecular Partners Announces Upcoming Top-Rated Oral Presentation on MP0712, a ²¹²Pb-labeled Radio-DARPin Therapeutic targeting DLL3 for Small Cell Lung Cancer co-developed with Orano Med, at EANM 2024
    Aug 26 Molecular Partners reports 1H results
    Aug 26 Molecular Partners Reports H1 2024 Corporate Highlights and Financials
    See more MOLN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.7
    52 Week Low 3.32
    Average Volume 21,391
    200-Day Moving Average 5.18
    50-Day Moving Average 5.36
    20-Day Moving Average 5.86
    10-Day Moving Average 5.63
    Average True Range 0.50
    RSI (14) 44.44
    ADX 19.8
    +DI 25.45
    -DI 20.08
    Chandelier Exit (Long, 3 ATRs) 6.09
    Chandelier Exit (Short, 3 ATRs) 6.62
    Upper Bollinger Bands 6.64
    Lower Bollinger Band 5.08
    Percent B (%b) 0.08
    BandWidth 26.63
    MACD Line -0.03
    MACD Signal Line 0.06
    MACD Histogram -0.0967
    Fundamentals Value
    Market Cap 170.84 Million
    Num Shares 32.9 Million
    EPS -2.09
    Price-to-Earnings (P/E) Ratio -2.49
    Price-to-Sales 17.37
    Price-to-Book 0.67
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.60
    Resistance 3 (R3) 5.64 5.55 5.53
    Resistance 2 (R2) 5.55 5.45 5.53 5.51
    Resistance 1 (R1) 5.37 5.38 5.33 5.33 5.49
    Pivot Point 5.28 5.28 5.26 5.26 5.28
    Support 1 (S1) 5.11 5.18 5.06 5.07 4.91
    Support 2 (S2) 5.02 5.12 5.00 4.89
    Support 3 (S3) 4.84 5.02 4.87
    Support 4 (S4) 4.80